Company / Accounts Receivable
GERON CORP Accounts Receivable History
FY2024-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$35.9M
FY2024
5-year range
$35.9M / $35.9M
FY2024-FY2024
Trend
-
vs FY2023
Sector context
#76 of 115
Health Care
What the data says
At $36M, GERON CORP's accounts receivable ranks #76 of 115 in the Health Care sector.
Based on SEC 10-K filings.
$36M in FY2024.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#76 of 115 in Health CareTop 66% of 115This company $35.9M Sector average $1.1B
▼
-96.8% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $35.9M | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026